Literature DB >> 21313858

Myxosarcomas associated with avian leukosis virus subgroup A infection in fancy breed chickens.

Susan M Williams1, Taylor Barbosa, Scott Hafner, Guillermo Zavala.   

Abstract

Formalin-fixed suspect tumors were submitted to the Poultry Diagnostic and Research Center at the University of Georgia (Athens, GA) for diagnosis. Samples were from fancy breed chickens with a history of increased tumor prevalence in both hens and roosters. Microscopically, in all the samples, there were neoplastic proliferations of spindle-shaped cells. The matrix surrounding tumor cells stained positively with Alcian blue at pH 2.5, but neoplastic cells did not stain with periodic acid-Schiff. Immunohistochemistry stains were positive for vimentin and neuron-specific enolase and negative for desmin, smooth muscle actin, and S-100 protein. Tumors were determined to be myxosarcomas. All samples were positive for PCR targeting the gp85 avian leukosis virus (ALV) envelope protein. However, analysis of the predicted amino acid sequences in the envelope gene from three separate samples showed high similarity between them and to ALV subgroup A.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21313858     DOI: 10.1637/9400-052110-Case.1

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  2 in total

1.  Polyostotic osteosarcoma associated with avian leukosis virus infection in a captive bare-faced curassow (Crax fasciolata).

Authors:  Jefferson Bruno Soares Oliveira; Ayisa Rodrigues de Oliveira; Daniel Oliveira Dos Santos; Thaynara Parente de Carvalho; Larissa Giannini Alves Moreira; Herlandes Penha Tinoco; Carlyle Mendes Coelho; Hannah Luiza Gonsalves Coelho; Maria Clara de Paiva Zucherato; Sandra Yuliet Marín-Gómez; Camila Siqueira Costa; Nelson R S Martins; Renato Lima Santos
Journal:  BMC Vet Res       Date:  2021-02-18       Impact factor: 2.741

2.  Avian leukosis virus (ALV) is highly prevalent in fancy-chicken flocks in Saxony.

Authors:  Markus Freick; Ruben Schreiter; Jim Weber; Thomas W Vahlenkamp; Kristin Heenemann
Journal:  Arch Virol       Date:  2022-03-17       Impact factor: 2.574

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.